These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 1491697)

  • 1. Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor.
    Drucker DJ; Lee YC; Asa SL; Brubaker PL
    Mol Endocrinol; 1992 Dec; 6(12):2175-84. PubMed ID: 1491697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line.
    Drucker DJ; Jin T; Asa SL; Young TA; Brubaker PL
    Mol Endocrinol; 1994 Dec; 8(12):1646-55. PubMed ID: 7535893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene.
    Brubaker PL; Lee YC; Drucker DJ
    J Biol Chem; 1992 Oct; 267(29):20728-33. PubMed ID: 1328210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region- and age-specific differences in proglucagon gene expression in the central nervous system of wild-type and glucagon-simian virus-40 T-antigen transgenic mice.
    Lee YC; Campos RV; Drucker DJ
    Endocrinology; 1993 Jul; 133(1):171-7. PubMed ID: 8319563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice.
    Drucker DJ
    Am J Physiol; 1994 Nov; 267(5 Pt 1):E629-35. PubMed ID: 7977712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pancreatic proglucagon gene expression in mice bearing subcutaneous endocrine tumors.
    Ehrlich P; Tucker D; Asa SL; Brubaker PL; Drucker DJ
    Am J Physiol; 1994 Nov; 267(5 Pt 1):E662-71. PubMed ID: 7977716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas.
    Philippe J; Mojsov S; Drucker DJ; Habener JF
    Endocrinology; 1986 Dec; 119(6):2833-9. PubMed ID: 3536450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pax-2 activates the proglucagon gene promoter but is not essential for proglucagon gene expression or development of proglucagon-producing cell lineages in the murine pancreas or intestine.
    Flock G; Drucker DJ
    Mol Endocrinol; 2002 Oct; 16(10):2349-59. PubMed ID: 12351699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.
    Dhanvantari S; Brubaker PL
    Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumor.
    Brubaker PL; Drucker DJ; Asa SL; Swallow C; Redston M; Greenberg GR
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3078-83. PubMed ID: 12107204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription.
    Hill ME; Asa SL; Drucker DJ
    Mol Endocrinol; 1999 Sep; 13(9):1474-86. PubMed ID: 10478839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
    Asa SL; Lee YC; Drucker DJ
    Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prohormone convertases in the tissue-specific processing of proglucagon.
    Dhanvantari S; Seidah NG; Brubaker PL
    Mol Endocrinol; 1996 Apr; 10(4):342-55. PubMed ID: 8721980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pdx-1 is not sufficient for repression of proglucagon gene transcription in islet or enteroendocrine cells.
    Flock G; Cao X; Drucker DJ
    Endocrinology; 2005 Jan; 146(1):441-9. PubMed ID: 15471960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
    Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
    Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proglucagon processing in islet and intestinal cell lines.
    Tucker JD; Dhanvantari S; Brubaker PL
    Regul Pept; 1996 Apr; 62(1):29-35. PubMed ID: 8738879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.
    Ugleholdt R; Zhu X; Deacon CF; Ørskov C; Steiner DF; Holst JJ
    Endocrinology; 2004 Mar; 145(3):1349-55. PubMed ID: 14630721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells.
    Dhanvantari S; Izzo A; Jansen E; Brubaker PL
    Endocrinology; 2001 Jan; 142(1):37-42. PubMed ID: 11145564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
    Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon and related peptides in fetal rat hypothalamus in vivo and in vitro.
    Lui EY; Asa SL; Drucker DJ; Lee YC; Brubaker PL
    Endocrinology; 1990 Jan; 126(1):110-7. PubMed ID: 2152861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.